Table 1.
Study | Antifungal | Volume fraction | Antifungal release (percent of loaded drug) | Bioactivity | Compressive strength (MPa) |
---|---|---|---|---|---|
Rouse et al. [14] | Anidulafungin, voriconazole | Not reported | Reported concentration only approximately 0.6% release by 24 hours | Not tested | Not tested |
Sealy et al. [15] | Flucytosine, fluconazole, micafungin, terbinafine, anidulafungin | Not reported | Flucytosine: 0.54% Fluconazole: 0.67% Micafungin: 0.04% Terbinafine: 0.07% Anidulafungin: 9.68% |
Drug activity reported variable | Not tested |
Kweon et al. [9] | Amphotericin B deoxycholate | < 3 vol% | 1% of amphotericin B recovered by Day 30 with poragen; 0.04% without poragen | Not tested | Compressive strength decreases with poragen; compressive strength slightly increased without poragen |
Grimsrud et al. [6] | Voriconazole | 30 vol% | Neither percent release or concentration measured; release present after 2 weeks | Active | Not tested |
Silverberg et al. [16] | Amphotericin B, fluconazole, 5-flucytosine | Not reported | Not measured | Amphotericin B, fluconazole active | Not tested |